Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
abingdonhealth.com

See what CB Insights has to offer

Founded Year

2008

Stage

IPO | IPO

Total Raised

$13.97M

Date of IPO

12/15/2020

Market Cap

0.06B

About Abingdon Health

Abingdon Health is commercializing Seralite‐ FLC Serum and Seralite– FLC Urine. These assays allow for the rapid quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs) as an aid to the diagnosis and management of multiple myeloma.

Abingdon Health Headquarter Location

National Innovation Campus Sand Hutton

York, England, YO41 1LZ,

United Kingdom

+44 (0) 121 414 5156

Latest Abingdon Health News

Exclusive manufacturing deal for medical tests specialist

Sep 13, 2021

Chris Yates, CEO, Abingdon Health Abingdon Health, an international developer and maker of rapid tests, has signed an exclusive manufacturing agreement with BioSure, which provides in-vitro diagnostic testing solutions. Under the terms of the exclusive deal, York-headquartered Abingdon will manufacture BioSure’s own lateral flow tests in the field of COVID-19. The contract manufacturing services will use lateral flow manufacturing facilities at Abingdon’s York and Doncaster sites. Chris Yates, CEO of Abingdon, said: “We are delighted to be supporting BioSure and building on our long-term collaboration with the BioSure team. We are committed to supporting the deployment of these much needed lateral flow test to the UK and international markets.” Brigette Bard, CEO of BioSure, added: “We are thrilled to be continuing to build our portfolio of products with Abingdon. “BioSure is committed to delivering British developed tests to the global market and Abingdon are our ideal partner to manufacture our world-leading products.” Join us at the 2021 Rainmaker Awards in Manchester on September 9 Previous Article

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Abingdon Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Abingdon Health is included in 5 Expert Collections, including Medical Devices.

M

Medical Devices

7,528 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,592 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health & Wellness Assessment

3,196 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

I

Infectious Disease

2,222 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

D

Digital Health

10,305 items

Companies using/incorporating digital tech into health, wellness, and life science offerings. Includes cos operating within the hc, consumer health, and life science industries + tech vendors catering to them. Excludes cos exclusively focused on fitness/sports & performance

Abingdon Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Abingdon Health Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.